AI Image
Pfizer CEO Touts $80 Billion In Deals - But 'The Real Test' Is Still Ahead
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information for educational purposes and does not offer investment advice or recommendations to buy or sell securities.
- The data presented is sourced from reliable providers but is not guaranteed for accuracy, timeliness, or suitability, and may change without notice.
- Past investment performance is not indicative of future results, and authors may hold positions in the stocks they discuss.
- Real-time pricing is provided by Nasdaq Last Sale, with ownership data from LSEG and estimates from FactSet, though not all market data is included.
- Investor’s Business Daily and related marks are registered trademarks of Investor’s Business Daily, LLC, which holds all rights to the content.
